Tags

Type your tag names separated by a space and hit enter

Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology.
J Viral Hepat. 2008 Oct; 15 Suppl 2:1-15.JV

Abstract

For the first time a global meeting on hepatitis A virus (HAV) infection as vaccine preventable disease was organized at the end of 2007. More than 200 experts from 46 countries gathered to investigate the changing global HAV epidemiology reflecting the increasing numbers of persons at risk for severe clinical disease and mortality from HAV infection. The benefits of childhood and adult hepatitis A (HepA) vaccination strategies and the data needed by individual countries and international health organizations to assess current HepA prevention strategies were discussed. New approaches in preventing HAV infection including universal HepA vaccination were considered. This introductory paper summarizes the major findings of the meeting and describes the changing epidemiology of HAV infections and the impact of HepA vaccination strategies in various countries. Implementation of HepA vaccination strategies should take into account the level of endemicity, the level of the socio-economic development and sanitation, and the risk of outbreaks. A stepwise strategy for introduction of HepA universal immunisation of children was recommended. This strategy should be based on accurate surveillance of cases and qualitative documentation of outbreaks and their control, secure political support on the basis of high-quality results, and comprehensive cost-effectiveness studies. The recognition of the need for increased global attention towards HepA prevention is an important outcome of this meeting.

Authors+Show Affiliations

Centre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Faculty of Medicine, Antwerp, Belgium. Greet.Hendrickx@ua.ac.beNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Introductory Journal Article

Language

eng

PubMed ID

18837827

Citation

Hendrickx, G, et al. "Has the Time Come to Control Hepatitis a Globally? Matching Prevention to the Changing Epidemiology." Journal of Viral Hepatitis, vol. 15 Suppl 2, 2008, pp. 1-15.
Hendrickx G, Van Herck K, Vorsters A, et al. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepat. 2008;15 Suppl 2:1-15.
Hendrickx, G., Van Herck, K., Vorsters, A., Wiersma, S., Shapiro, C., Andrus, J. K., Ropero, A. M., Shouval, D., Ward, W., & Van Damme, P. (2008). Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. Journal of Viral Hepatitis, 15 Suppl 2, 1-15. https://doi.org/10.1111/j.1365-2893.2008.01022.x
Hendrickx G, et al. Has the Time Come to Control Hepatitis a Globally? Matching Prevention to the Changing Epidemiology. J Viral Hepat. 2008;15 Suppl 2:1-15. PubMed PMID: 18837827.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. AU - Hendrickx,G, AU - Van Herck,K, AU - Vorsters,A, AU - Wiersma,S, AU - Shapiro,C, AU - Andrus,J K, AU - Ropero,A M, AU - Shouval,D, AU - Ward,W, AU - Van Damme,P, PY - 2008/10/22/pubmed PY - 2008/12/31/medline PY - 2008/10/22/entrez SP - 1 EP - 15 JF - Journal of viral hepatitis JO - J. Viral Hepat. VL - 15 Suppl 2 N2 - For the first time a global meeting on hepatitis A virus (HAV) infection as vaccine preventable disease was organized at the end of 2007. More than 200 experts from 46 countries gathered to investigate the changing global HAV epidemiology reflecting the increasing numbers of persons at risk for severe clinical disease and mortality from HAV infection. The benefits of childhood and adult hepatitis A (HepA) vaccination strategies and the data needed by individual countries and international health organizations to assess current HepA prevention strategies were discussed. New approaches in preventing HAV infection including universal HepA vaccination were considered. This introductory paper summarizes the major findings of the meeting and describes the changing epidemiology of HAV infections and the impact of HepA vaccination strategies in various countries. Implementation of HepA vaccination strategies should take into account the level of endemicity, the level of the socio-economic development and sanitation, and the risk of outbreaks. A stepwise strategy for introduction of HepA universal immunisation of children was recommended. This strategy should be based on accurate surveillance of cases and qualitative documentation of outbreaks and their control, secure political support on the basis of high-quality results, and comprehensive cost-effectiveness studies. The recognition of the need for increased global attention towards HepA prevention is an important outcome of this meeting. SN - 1365-2893 UR - https://www.unboundmedicine.com/medline/citation/18837827/Has_the_time_come_to_control_hepatitis_A_globally_Matching_prevention_to_the_changing_epidemiology_ L2 - https://doi.org/10.1111/j.1365-2893.2008.01022.x DB - PRIME DP - Unbound Medicine ER -